Malignant transformation of B cells can occur at various steps of lymphocyt
e development, starting from early B-cell progenitors up to mature B cells,
which reflects the heterogeneity of B-cell malignancies with regard to the
ir biologic and clinical behavior. The genetic characterization of B-cell n
eoplasms during the past two decades has elucidated the mechanisms underlyi
ng B-cell lymphomagenesis and led to a more precise definition of lymphoma
subgroups. This progress is reflected in the upcoming World Health Organiza
tion classification for hematologic neoplasms, which stresses the diagnosti
c importance of recurrent genetic alterations in leukemias and lymphomas. I
n the recent past, several genes deregulated by such recurrent chromosomal
aberrations have been identified. In addition, the recent introduction of m
icroarray technology has now allowed a more global assessment of gene dysre
gulation in B-cell oncogenesis and provided a new means for more exactly de
fining the molecular hallmarks of distinct lymphoma subtypes. This review w
ill focus on recently described molecular features of B-cell lymphomas disc
overed by the application of new molecular cytogenetic techniques, advanced
breakpoint cloning strategies, and microarray approaches. Curr Opin Oncol
2001, 13:316-324 (C) 2001 Lippincott Williams & Wilkins, Inc.